The business of cellular therapy and hematopoietic stem cell transplantation

Peggy Appel; Richard T. Maziarz

doi:10.1007/978-1-4419-7506-5_2

The business of cellular therapy and hematopoietic stem cell transplantation

Peggy Appel, Richard T. Maziarz

Knight Cancer Institute

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Hematopoietic stem cell transplant (HSCT) is a complex process that is associated with a heavy demand for resources and need for multispecialty teams. The first transplant procedures were performed over 40 years ago. There has been a dramatic increase in the number of procedures performed over the past 10 years (Fig. 2.1)

Original language	English (US)
Title of host publication	Blood and Marrow Transplant Handbook
Subtitle of host publication	Comprehensive Guide for Patient Care
Publisher	Springer New York
Pages	9-19
Number of pages	11
ISBN (Print)	9781441975058
DOIs	https://doi.org/10.1007/978-1-4419-7506-5_2
State	Published - 2011

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4419-7506-5_2

Cite this

@inbook{c5f0e87fca914f13a6950262817afb3a,

title = "The business of cellular therapy and hematopoietic stem cell transplantation",

abstract = "Hematopoietic stem cell transplant (HSCT) is a complex process that is associated with a heavy demand for resources and need for multispecialty teams. The first transplant procedures were performed over 40 years ago. There has been a dramatic increase in the number of procedures performed over the past 10 years (Fig. 2.1)",

author = "Peggy Appel and Maziarz, {Richard T.}",

year = "2011",

doi = "10.1007/978-1-4419-7506-5_2",

language = "English (US)",

isbn = "9781441975058",

pages = "9--19",

booktitle = "Blood and Marrow Transplant Handbook",

publisher = "Springer New York",

}

TY - CHAP

T1 - The business of cellular therapy and hematopoietic stem cell transplantation

AU - Appel, Peggy

AU - Maziarz, Richard T.

PY - 2011

Y1 - 2011

N2 - Hematopoietic stem cell transplant (HSCT) is a complex process that is associated with a heavy demand for resources and need for multispecialty teams. The first transplant procedures were performed over 40 years ago. There has been a dramatic increase in the number of procedures performed over the past 10 years (Fig. 2.1)

AB - Hematopoietic stem cell transplant (HSCT) is a complex process that is associated with a heavy demand for resources and need for multispecialty teams. The first transplant procedures were performed over 40 years ago. There has been a dramatic increase in the number of procedures performed over the past 10 years (Fig. 2.1)

UR - http://www.scopus.com/inward/record.url?scp=84892231332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892231332&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-7506-5_2

DO - 10.1007/978-1-4419-7506-5_2

M3 - Chapter

AN - SCOPUS:84892231332

SN - 9781441975058

SP - 9

EP - 19

BT - Blood and Marrow Transplant Handbook

PB - Springer New York

ER -

The business of cellular therapy and hematopoietic stem cell transplantation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this